Trials / Unknown
UnknownNCT05109377
Endocan Level in Patients With Erectile Dysfunction and Relationship With Tadalafil Treatment
- Status
- Unknown
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 90 (estimated)
- Sponsor
- Ankara Training and Research Hospital · Academic / Other
- Sex
- Male
- Age
- 18 Years – 65 Years
- Healthy volunteers
- Accepted
Summary
The investigators analyze the patients' endocan levels, IIEF scores, and hormon levels both before and after tadalafil (5 or 20mg) treatment. The investigators want to see erectile dysfunction severity and tadalafil treatment relations with endocen level.
Detailed description
The investigators will include at least 90 patients in study. Blood tests will taken before and after tadalafil treatment and will store at -80 celcius degree.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIAGNOSTIC_TEST | Endocan | Endocan will measured before and after treatment |
| DRUG | tadalafil | tadalafil |
Timeline
- Start date
- 2021-06-24
- Primary completion
- 2021-11-15
- Completion
- 2021-12-15
- First posted
- 2021-11-05
- Last updated
- 2021-11-05
Locations
1 site across 1 country: Turkey (Türkiye)
Source: ClinicalTrials.gov record NCT05109377. Inclusion in this directory is not an endorsement.